Edition:
India

Horizon Pharma reports Q3 Non-GAAP earnings per share $0.26


Monday, 6 Nov 2017 

Nov 6 (Reuters) - Horizon Pharma Plc : :Horizon Pharma plc announces third-quarter and year-to-date 2017 results.Q3 sales $271.6 million versus I/B/E/S view $259.7 million.Q3 earnings per share view $0.22 -- Thomson Reuters I/B/E/S.Sees FY 2017 sales $1.03 billion to $1.05 billion.Q3 GAAP loss per share $0.39.Q3 Non-GAAP earnings per share $0.26.Horizon Pharma plc says sees FY 2017 ‍adjusted EBITDA guidance range of $350 million to $375 million from $340 million to $375 million.Horizon Pharma says sees Krystexxa 2018 net sales up more than 50 percent​. 

Company Quote

22.81
-0.79 -3.35%
14 Jun 2019